Rodriguez-Otero, P., Dholaria, B., Askari, E., Reece, D., van de Donk, N., Chari, A., Goldschmidt, H., Krishnan, A., Martin, T., Mateos, M., Morillo, D., Rodriguez, C., Rosinol, L., San-Miguel, J., Balari, A., Wäsch, R., Weisel, K., Verona, R., Lin, S., Prior, T., Wade, M., Weiss, B., Goldberg, J., Oriol, A., & Hari, P. (n.d.). b04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY. HemaSphere, 6, 7–8. http://access.bl.uk/ark:/81055/vdc_100153435583.0x000033